Elimination of saphenous reflux after tributary sclerotherapy: report of two cases
Abolição do refluxo de safena após escleroterapia de colaterais: relato de dois casos
Felipe Puricelli Faccini; Claudia Carvalho Sathler-Melo
Abstract
Keywords
Resumo
Resumo: A maioria dos pacientes com insuficiência venosa crônica e refluxo na veia safena é tratada com retirada ou ablação da safena. A hemodinâmica venosa traz a possibilidade de tratar esses pacientes sem eliminar a veia safena. Nós apresentamos dois casos de refluxo parcial de veia safena magna resolvidos com escleroterapia hemodinâmica. Usamos um protocolo de uso sinergístico de glicose 75% e Nd-YAG laser 1064. Os casos nos mostram que o tratamento das tributárias pode corrigir o refluxo da veia safena e obter melhora clínica e cosmética. Os resultados de longo prazo ainda são incertos.
Palavras-chave
References
1 Walsh JC, Bergan JJ, Beeman S, Comer TP. Femoral venous reflux abolished by greater saphenous vein stripping. Ann Vasc Surg. 1994;8(6):566-70.
2 Luccas GC, Kauffman P, Lane JC. Método de avaliaçäo do estudo funcional da veia safena interna. Cir Vasc Angiol. 1985;1(3):22-8.
3 Franceschi C, Zamboni P. Principles of venous hemodynamics. New York: Nova Biomedical Books; 2009.
4 Chastanet S, Pittaluga P. Ten-year outcomes of treatment of varicose veins by Ambulatory Selective Ablation of Varices Under Local Anesthesia (ASVAL). J Vasc Surg Venous Lymphat Disord. 2018;6(2):289.
5 Baber JT Jr, Mao J, Sedrakyan A, Connolly PH, Meltzer AJ. Impact of provider characteristics on use of endovenous ablation procedures in Medicare beneficiaries. J Vasc Surg Venous Lymphat Disord. 2019;7(2):203-9.e1.
6 Crawford JM, Gasparis A, Almeida J, et al. A review of United States endovenous ablation practice trends from the Medicare Data Utilization and Payment Database. J Vasc Surg Venous Lymphat Disord. 2019;7(4):471-9.
7 Guillaume GM, Meeus P, Dalcq V, van der Borght L, Vuylsteke ME, Maeseneer MG. Influence of reimbursement policies on phlebological surgical practice in Belgium between 2007 and 2017. Int Angiol. 2020;39(4):267-75.
8 Paravastu SCV, Horne M, Dodd PDF. Endovenous ablation therapy (laser or radiofrequency) or foam sclerotherapy versus conventional surgical repair for short saphenous varicose veins. Cochrane Database Syst Rev. 2016;11:CD010878.
9 Karam B, Haddad F, Ataya K, Jaafar R, Nassar H. Long-term results of Endovenous Laser Therapy (EVLT) of saphenous vein reflux: up to 9 years follow-up. Eur J Vasc Endovasc Surg. 2019;58(6):e766.
10 Flessenkämper I, Hartmann M, Hartmann K, Stenger D, Roll S. Endovenous laser ablation with and without high ligation compared to high ligation and stripping for treatment of great saphenous varicose veins: Results of a multicentre randomised controlled trial with up to 6 years follow-up. Phlebology. 2016;31(1):23-33.
11 Fischer R, Linde N, Duff C, Jeanneret C, Chandler JG, Seeber P. Late recurrent saphenofemoral junction reflux after ligation and stripping of the greater saphenous vein. J Vasc Surg. 2001;34(2):236-40.
12 Faccini FP, Ermini S, Franceschi C. CHIVA to treat saphenous vein insufficiency in chronic venous disease: characteristics and results. J Vasc Bras. 2019;18:e20180099.
13 Franceschi C, Cappelli M, Ermini S, et al. CHIVA: hemodynamic concept, strategy and results. Int Angiol. 2016;35(1):8-30. PMid:26044838.
14 Mendoza E, Cappelli M. Sclerotherapy technique in CHIVA strategy. Phlebologie. 2018;46(02):66-74.
15 Miyake RK. Cryo-laser and cryo-sclerotherapy guided by augmented reality: report of 140 cases. Phlebologie. 2014;43(5):257-61.
16 Ganesh S. Depth and size limits for the visibility of veins using the veinviewer imaging system. Memphis: University of Tennessee Health Science Center; 2007.
17 Lawrence PF, Gloviczki P. Appropriate care for venous disease. J Vasc Surg Venous Lymphat Disord. 2019;7(4):469-70.
18 Nesbitt C, Bedenis R, Bhattacharya V, Stansby G. Endovenous ablation (radiofrequency and laser) and foam sclerotherapy versus open surgery for great saphenous vein varices. Cochrane Database Syst Rev. 2014;(7):CD005624.
19 Pfisterer L, König G, Hecker M, Korff T. Pathogenesis of varicose veins: lessons from biomechanics. Vasa. 2014;43(2):88-99.
20 Cappelli M, Molino-Lova R, Giangrandi I, Ermini S, Gianesini S. Ligation of the saphenofemoral junction tributaries as risk factor for groin recurrence. J Vasc Surg Venous Lymphat Disord. 2018;6(2):224-9.
21 Engelhorn CA, Engelhorn ALV, Cassou MF, Salles-Cunha S. Patterns of saphenous venous reflux in women presenting with lower extremity telangiectasias. Dermatol Surg. 2007;33(3):282-8. PMid:17338684.
22 Martinez-Zapata MJ, Vernooij RWM, Uriona Tuma SM, et al. Phlebotonics for venous insufficiency. Cochrane Database Syst Rev. 2016;4:CD003229. PMid:27048768.
23 Campbell B, Franklin IJ, Gohel M. The choice of treatments for varicose veins: a study in trade-offs. Phlebology. 2020;35(9):647-9.
24 Fowkes FG, Evans CJ, Lee AJ. Prevalence and risk factors of chronic venous insufficiency. Angiology. 2001;52(1, Suppl 1):S5-15.
25 Zimmet SE. Sclerotherapy treatment of telangiectasias and varicose veins. Tech Vasc Interv Radiol. 2003;6(3):116-20.
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email